Immunotherapy: HLA-1 genotype influences response to checkpoint inhibitors – Nature.com
|
Immunotherapy: HLA-1 genotype influences response to checkpoint inhibitors
Nature.com Immunotherapy: HLA-1 genotype influences response to checkpoint inhibitors. Peter Sidaway. The introduction of immune-checkpoint inhibitors has dramatically improved the survival outcomes of certain patients with advanced-stage cancers; however, the … |
